Fusion Antibodies PLC (LON:FAB)
12.75p-1.92%
Spriggl Score: Weak— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Gross margins doubled to fifty percent but negative equity signals severe distress requiring non-dilutive funding.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Fusion Antibodies PLC
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offe…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £17.8M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Fusion Antibodies PLC and 1,600+ UK and US stocks.
Start free